Robin Garner
Stock Analyst at Craig-Hallum
(0.82)
# 3,732
Out of 4,761 analysts
4
Total ratings
25%
Success rate
-8.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robin Garner
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XERS Xeris Biopharma Holdings | Initiates: Buy | $4.5 | $3.75 | +20.00% | 2 | Aug 28, 2023 | |
| CUE Cue Biopharma | Maintains: Buy | $28 → $26 | $1.32 | +1,869.70% | 1 | Mar 18, 2022 | |
| FENC Fennec Pharmaceuticals | Initiates: Buy | $17 | $6.65 | +155.64% | 1 | Apr 21, 2021 |
Xeris Biopharma Holdings
Aug 28, 2023
Initiates: Buy
Price Target: $4.5
Current: $3.75
Upside: +20.00%
Cue Biopharma
Mar 18, 2022
Maintains: Buy
Price Target: $28 → $26
Current: $1.32
Upside: +1,869.70%
Fennec Pharmaceuticals
Apr 21, 2021
Initiates: Buy
Price Target: $17
Current: $6.65
Upside: +155.64%